X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 51 filers reported holding X4 PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,345 | -52.5% | 11,326 | -15.5% | 0.00% | – |
Q2 2023 | $25,996 | +116.6% | 13,400 | +841.7% | 0.00% | – |
Q1 2021 | $12,000 | +33.3% | 1,423 | 0.0% | 0.00% | – |
Q4 2020 | $9,000 | -10.0% | 1,423 | 0.0% | 0.00% | – |
Q3 2020 | $10,000 | -41.2% | 1,423 | -23.5% | 0.00% | – |
Q2 2020 | $17,000 | -19.0% | 1,861 | -21.5% | 0.00% | – |
Q1 2020 | $21,000 | -22.2% | 2,372 | -4.8% | 0.00% | – |
Q4 2019 | $27,000 | +8.0% | 2,492 | +25.8% | 0.00% | – |
Q3 2019 | $25,000 | +47.1% | 1,981 | +70.0% | 0.00% | – |
Q2 2019 | $17,000 | +750.0% | 1,165 | +782.6% | 0.00% | – |
Q1 2019 | $2,000 | – | 132 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 311,490 | $532,000 | 1.65% |
Bain Capital Life Sciences Investors, LLC | 6,389,436 | $10,926,000 | 1.30% |
Tri Locum Partners LP | 2,504,006 | $4,282,000 | 1.18% |
Sio Capital Management, LLC | 1,418,461 | $2,426,000 | 0.77% |
NEA Management Company, LLC | 6,523,157 | $11,155,000 | 0.56% |
AIGH Capital Management LLC | 997,719 | $1,706,000 | 0.53% |
Parkman Healthcare Partners LLC | 950,000 | $1,625,000 | 0.46% |
New Leaf Venture Partners, L.L.C. | 335,000 | $573,000 | 0.34% |
Worth Venture Partners, LLC | 250,144 | $428,000 | 0.26% |
Ikarian Capital, LLC | 568,612 | $973,000 | 0.19% |